DNASE1
Basic information
Region (hg38): 16:3611728-3680143
Previous symbols: [ "DNL1" ]
Links
Phenotypes
GenCC
Source:
- systemic lupus erythematosus (No Known Disease Relationship), mode of inheritance: Unknown
- autosomal systemic lupus erythematosus type 16 (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNASE1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 13 | ||||
missense | 12 | 20 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 60 | 31 | 15 | 106 | ||
Total | 0 | 1 | 74 | 46 | 21 |
Variants in DNASE1
This is a list of pathogenic ClinVar variants found in the DNASE1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-3655386-A-T | Systemic lupus erythematosus, susceptibility to | risk factor (Aug 01, 2001) | ||
16-3655426-A-C | not specified | Uncertain significance (Nov 05, 2021) | ||
16-3655434-G-A | not specified | Uncertain significance (Apr 26, 2024) | ||
16-3655453-C-T | Uncertain significance (Jul 06, 2021) | |||
16-3655464-C-T | Systemic lupus erythematosus | Likely pathogenic (Apr 04, 2024) | ||
16-3655478-G-C | Likely benign (Jul 01, 2024) | |||
16-3655492-A-G | not specified | Uncertain significance (Mar 31, 2022) | ||
16-3655499-C-T | DNASE1-related disorder | Likely benign (Dec 05, 2019) | ||
16-3655869-C-T | DNASE1-related disorder | Likely benign (Jun 05, 2019) | ||
16-3655934-A-C | DNASE1-related disorder | Uncertain significance (Apr 26, 2024) | ||
16-3656145-G-C | not specified | Uncertain significance (Sep 20, 2022) | ||
16-3656165-G-A | Likely benign (Dec 01, 2023) | |||
16-3656184-A-G | Benign (Sep 01, 2022) | |||
16-3656642-G-C | not specified | Uncertain significance (Apr 18, 2023) | ||
16-3656667-A-C | Benign (May 01, 2024) | |||
16-3656695-C-T | DNASE1-related disorder | Likely benign (Apr 25, 2019) | ||
16-3656696-G-A | Systemic lupus erythematosus | Benign (-) | ||
16-3656702-G-A | Systemic lupus erythematosus | Uncertain significance (Jun 09, 2022) | ||
16-3656715-G-A | Systemic lupus erythematosus | Uncertain significance (Mar 26, 2024) | ||
16-3656727-T-C | Uncertain significance (Aug 14, 2023) | |||
16-3656979-C-T | Uncertain significance (May 01, 2020) | |||
16-3657001-G-A | Likely benign (Mar 01, 2022) | |||
16-3657015-C-T | Likely benign (May 01, 2024) | |||
16-3657022-C-G | DNASE1-related disorder | Benign (Jan 14, 2020) | ||
16-3657063-C-T | DNASE1-related disorder | Likely benign (Jan 02, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNASE1 | protein_coding | protein_coding | ENST00000246949 | 8 | 68416 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.98e-21 | 0.0000343 | 125539 | 0 | 209 | 125748 | 0.000831 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.55 | 264 | 170 | 1.55 | 0.0000111 | 1821 |
Missense in Polyphen | 112 | 72.222 | 1.5508 | 795 | ||
Synonymous | -3.56 | 121 | 80.4 | 1.51 | 0.00000624 | 568 |
Loss of Function | -2.34 | 25 | 15.2 | 1.65 | 8.02e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00136 | 0.00136 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000659 | 0.000598 |
Finnish | 0.000421 | 0.000416 |
European (Non-Finnish) | 0.000686 | 0.000677 |
Middle Eastern | 0.000659 | 0.000598 |
South Asian | 0.00215 | 0.00213 |
Other | 0.000985 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Serum endocuclease secreted into body fluids by a wide variety of exocrine and endocrine organs (PubMed:2251263, PubMed:11241278, PubMed:2277032). Expressed by non-hematopoietic tissues and preferentially cleaves protein-free DNA (By similarity). Among other functions, seems to be involved in cell death by apoptosis (PubMed:11241278). Binds specifically to G- actin and blocks actin polymerization (By similarity). Together with DNASE1L3, plays a key role in degrading neutrophil extracellular traps (NETs) (By similarity). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (By similarity). Degradation of intravascular NETs by DNASE1 and DNASE1L3 is required to prevent formation of clots that obstruct blood vessels and cause organ damage following inflammation (By similarity). {ECO:0000250|UniProtKB:P00639, ECO:0000250|UniProtKB:P21704, ECO:0000250|UniProtKB:P49183, ECO:0000269|PubMed:11241278, ECO:0000269|PubMed:2251263, ECO:0000269|PubMed:2277032}.;
- Disease
- DISEASE: Systemic lupus erythematosus (SLE) [MIM:152700]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:11479590, ECO:0000269|PubMed:20439745}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Neutrophil extracellular traps (NETs) are impaired in patients suffering from SLE (PubMed:20439745). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (PubMed:20439745). {ECO:0000269|PubMed:20439745}.;
Recessive Scores
- pRec
- 0.356
Intolerance Scores
- loftool
- 0.609
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.63
Haploinsufficiency Scores
- pHI
- 0.144
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.606
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnase1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; immune system phenotype;
Gene ontology
- Biological process
- DNA catabolic process, endonucleolytic;neutrophil activation involved in immune response;regulation of acute inflammatory response;DNA catabolic process;apoptotic process;regulation of neutrophil mediated cytotoxicity
- Cellular component
- extracellular region;nucleus;nuclear envelope;extracellular exosome
- Molecular function
- DNA binding;actin binding;deoxyribonuclease I activity;deoxyribonuclease activity;protein binding